Zenlabs Ethica Peer Comparison

BSE: 530697

₹29.85

₹2.16 (7.80%)

As on 19-Oct-2026 15:32IST

Market cap

₹20 Cr

Revenue (TTM)

₹50 Cr

P/E Ratio

P/B Ratio

2.5

Div. Yield

0 %

Edit

	Zenlabs Ethica	Shilpa Medicare	Caplin Point Lab	Pfizer	Eris Lifesciences
Market cap (₹ Cr)	20	17,407	17,329	17,482	15,666
Revenue (₹ Cr)	50	1,682	2,287	2,570	3,230
Net Profit (₹ Cr)	-2.54	273.51	678.07	735.15	666.92
Net Margin (%)	-5.10	16.19	28.10	26.88	20.60
RoE (%)	-4.90	11.15	19.73	19.16	18.75
Price to Earnings	--	58.55	26.05	23.78	24.33
Price-To-Book	2.47	6.48	4.72	3.97	3.89

Income Statement (₹ Cr)

	Zenlabs Ethica	Shilpa Medicare	Caplin Point Lab	Pfizer	Eris Lifesciences
Operating Revenue	49.62	1,682.47	2,287.33	2,569.77	3,229.67
Total Income	49.80	1,689.83	2,413.29	2,735.39	3,237.12
Total Expenditure	48.67	1,203.91	1,490.75	1,628.14	2,090.06
EBITDA	0.95	478.55	796.58	941.63	1,139.61
Depreciation	0.71	126.01	78.10	57.58	281.06
EBIT	0.25	352.55	718.48	884.05	858.55
Interest	0.76	52.11	0.88	7.69	190.64
Other Income	0.18	7.37	125.96	165.62	7.45
Exceptional Items	-2.08	12.16	0.00	-49.16	-17.24
Profit before Tax	-2.41	319.96	843.56	992.82	658.12
Provision for Tax	0.13	46.45	165.49	257.67	-8.80
Profit after Tax	-2.54	273.51	678.07	735.15	666.92

	Zenlabs Ethica	Shilpa Medicare	Caplin Point Lab	Pfizer	Eris Lifesciences
Shareholder's Funds	8.51	2,591.20	3,586.42	4,202.90	3,902.67
Minority Interest	0.00	0.00	-12.71	0.00	-21.81
Non-Current Liabilities	1.57	266.35	28.74	91.50	1,392.75
Current Liabilities	27.12	848.06	385.94	627.48	2,077.10
Total Liabilities	40.62	3,310.68	3,207.85	4,911.11	6,865.52

	Zenlabs Ethica	Shilpa Medicare	Caplin Point Lab	Pfizer	Eris Lifesciences
Non-Current Assets	1.55	2,525.44	1,291.22	770.28	5,617.77
Current Assets	35.10	1,109.77	2,585.66	3,803.22	1,539.85
Total Assets	40.62	3,310.68	3,207.85	4,911.11	6,865.52
Total Debt*	11.88	586.37	0.55	2.50	2,421.66
Net Current Assets	7.98	261.71	2,199.72	3,175.74	-537.25
Contingent Liabilities	0.07	76.22	0.64	363.79	51.96

	Zenlabs Ethica	Shilpa Medicare	Caplin Point Lab	Pfizer	Eris Lifesciences
Cash From Operating Activities	3.83	132.27	432.37	659.75	1,065.01
Cash Flow from Investing Activities	0.14	-199.13	-334.73	-71.34	-79.97
Cash from Financing Activities	-3.08	62.65	-38.32	-205.34	-881.32
Net Cash Inflow / Outflow	0.88	-4.21	59.32	383.07	103.72

	Zenlabs Ethica	Shilpa Medicare	Caplin Point Lab	Pfizer	Eris Lifesciences
ROCE (%)	5.96	6.95	26.22	26.21	13.59
ROE (%)	-4.90	11.15	19.73	19.16	18.75
ROA (%)	-6.52	7.80	18.69	14.95	9.26
EBIT Margin (%)	0.50	20.95	31.41	34.40	26.58
Net Margin (%)	-5.10	16.19	28.10	26.88	20.60
Cash Profit Margin (%)	0.00	0.00	0.00	0.00	0.00

	Zenlabs Ethica	Shilpa Medicare	Caplin Point Lab	Pfizer	Eris Lifesciences
Revenue Growth (%)	-1.81	27.91	15.01	10.69	9.59
EBIT Growth (%)	-80.46	58.32	18.45	24.14	16.84
Net Profit Growth (%)	-1,076.54	149.56	19.61	-9.09	62.68
EPS Growth (%)	-279.69	-3.57	17.73	14.40	67.41
Book Value Growth (%)	2.98	30.63	23.77	17.30	10.19

	Zenlabs Ethica	Shilpa Medicare	Caplin Point Lab	Pfizer	Eris Lifesciences
Price / Earnings	-38.58	65.42	26.28	22.65	23.97
Price / Book Value	2.27	6.83	4.76	3.97	3.93
Dividend Yield (%)	0.00	0.06	0.35	1.96	0.00
EV/EBITDA	29.49	39.60	20.69	15.26	15.86
Market Cap (₹ Cr)	20.32	6,484.12	15,219.80	18,318.10	19,292.77

	Zenlabs Ethica	Shilpa Medicare	Caplin Point Lab	Pfizer	Eris Lifesciences
Debt to Equity	0.02	0.07	0.00	0.00	0.24
Short term debt to equity ratio	1.06	0.13	0.00	0.00	0.14
Current Ratio	1.29	1.31	6.70	6.06	0.74
Quick Ratio	0.74	0.88	5.59	5.31	0.53
Interest Coverage	-2.17	7.14	959.59	130.11	4.45

	Zenlabs Ethica	Shilpa Medicare	Caplin Point Lab	Pfizer	Eris Lifesciences
Debtors to sales (%)	31.65	30.84	36.10	7.07	21.07
Asset Turnover	1.28	0.48	0.63	0.52	0.45
Receivable days	142.89	118.15	110.70	29.10	54.06
Inventory Days	89.06	98.29	65.86	69.53	32.16
Payable days	129.56	128.16	105.88	76.77	140.91
Cash Conversion Cycle	102.39	88.28	70.68	21.86	-54.69

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.